Targeting Brain Cancer Stem Cells, New Screening Strategy
10/12/2011
According to a new study, published in the October issue of Molecular Cancer Therapeutics, a peer-reviewed journal of the American Association of Cancer Research, stem cells responsible for creating deadly brain tumors can be identified and characterized by chemical compounds that can target the stem cells...
Talactoferrin Phase II Trial In Non-Small Cell Lung Cancer Shows Promise
10/12/2011
Data from a Phase II randomized, double-blind, placebo-controlled clinical trial which assessed talactoferrin (an oral immunotherapy) in individuals who had previously received treatment for non-small cell lung cancer (NSCLC) has been published and will appear in the November 1, 2011 print issue of the peer-reviewed medical journal, Journal of Clinical Oncology, Agennix AG ...
Water Channels In The Body Help Cells Remain In Balance
10/12/2011
Water channels exist not only in nature - microscopical water channels are also present in the cells of the body, where they ensure that water can be transported through the protective surface of the cell...
Increased Prostate Cancer Risk From Vitamin E Supplements
10/12/2011
Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial. The results of this update will appear October 12, 2011, in the Journal of the American Medical Association...
BRCA2 Genetic Mutation Associated With Improved Survival And Chemotherapy Response In Ovarian Cancer
10/12/2011
Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA wild-type (genetic type used as a reference to compare genetic mutations), according to a study in the October 12 issue of JAMA...
Ovarian Cancer Patients Survive Longer With BRCA2 Mutated In Tumors
10/12/2011
Women with high-grade ovarian cancer live longer and respond better to platinum-based chemotherapy when their tumors have BRCA2 genetic mutations, researchers at The University of Texas MD Anderson Cancer Center and the Institute for Systems Biology report in the Oct. 12 issue of the Journal of the American Medical Association...
Ginger Root Supplement Reduced Colon Inflammation Markers
10/12/2011
Ginger supplements reduced markers of colon inflammation in a select group of patients, suggesting that this supplement may have potential as a colon cancer prevention agent, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research. Suzanna M. Zick, N.D., M.P.H...
Researchers Develop New Way To Screen For Brain Cancer Stem Cell Killers
10/12/2011
Researchers with UCLA's Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors. Glioblastoma is one of the deadliest malignancies, typically killing patients within 12 to 18 months...
Increased Prostate Cancer Risk From Vitamin E Supplements
10/12/2011
Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial. The results of this update will appear October 12, 2011, in the Journal of the American Medical Association...
BRCA2 Genetic Mutation Associated With Improved Survival And Chemotherapy Response In Ovarian Cancer
10/12/2011
Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA wild-type (genetic type used as a reference to compare genetic mutations), according to a study in the October 12 issue of JAMA...